NCX 470 Exerts Retinal Cell Protection and Enhances Ophthalmic Artery Blood Flow After Ischemia/Reperfusion Injury of Optic Nerve Head and Retina

PURPOSE: The purpose of this study was to assess the retinal protective activity and ocular hemodynamics after NCX 470 (0.1%) compared to bimatoprost administered as the US Food and Drug Administration (FDA)-approved drug (Lumigan − 0.01% ophthalmic solution, LUM) and at an equimolar dose (0.072%, B...

Descripción completa

Detalles Bibliográficos
Autores principales: Sgambellone, Silvia, Marri, Silvia, Villano, Serafina, Masini, Emanuela, Provensi, Gustavo, Bastia, Elena, Galli, Corinna, Brambilla, Stefania, Impagnatiello, Francesco, Lucarini, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2023
Materias:
Neuro-Ophthalmology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541723/
https://www.ncbi.nlm.nih.gov/pubmed/37750744
http://dx.doi.org/10.1167/tvst.12.9.22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541723/
https://www.ncbi.nlm.nih.gov/pubmed/37750744
http://dx.doi.org/10.1167/tvst.12.9.22

Ejemplares similares